Combination of HIV-1 Antibodies 3BNC117 and 10-1074 Delays Viral Rebound During Treatment Interruption

被引：0
|
作者：
Mendoza, Pilar [1 ]
Gruell, Henning [2 ]
Lu, Ching-Lan [1 ]
Butler, Allison [1 ]
Pai, Joy [1 ]
Nogueira, Lilian [1 ]
Oliveira, Thiago Y. [1 ]
Lorenzi, Julio C. C. [1 ]
Cohen, Yehuda Z. [1 ]
Millard, Katrina [1 ]
Unson-O'Brien, Cecille [1 ]
Belblidia, Shiraz A. [1 ]
Patel, Roshni [1 ]
Witmer-Pack, Maggi [1 ]
Schimeliovich, Irina [1 ]
Jankovic, Mila [1 ]
Seaman, Michael S. [3 ]
Klein, Florian [2 ]
Caskey, Marina [1 ]
Nussenzweig, Michel C. [1 ]
机构：
[1] Rockefeller Univ, New York, NY USA
[2] Univ Cologne, Cologne, Germany
[3] Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OA08.01
引用
收藏
页码：34 / 34
页数：1
相关论文
共 30 条
  • [21] Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption
    Mdluli, Thembi
    Slike, Bonnie M.
    Curtis, Daniel J.
    Shubin, Zhanna
    Tran, Ursula
    Li, Yifan
    Dussupt, Vincent
    Mendez-Rivera, Letzibeth
    Pinyakorn, Suteeraporn
    Stieh, Daniel J.
    Tomaka, Frank L.
    Schuitemaker, Hanneke
    Pau, Maria G.
    Colby, Donn J.
    Kroon, Eugene
    Sacdalan, Carlo
    de Souza, Mark
    Phanupak, Nittaya
    Hsu, Denise C.
    Ananworanich, Jintanat
    Ake, Julie A.
    Trautmann, Lydie
    Vasan, Sandhya
    Robb, Merlin L.
    Krebs, Shelly J.
    Paquin-Proulx, Dominic
    Rolland, Morgane
    CELL REPORTS, 2024, 43 (06):
  • [22] Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
    von Wyl, Viktor
    Gianella, Sara
    Fischer, Marek
    Niederoest, Barbara
    Kuster, Herbert
    Battegay, Manuel
    Bernasconi, Enos
    Cavassini, Matthias
    Rauch, Andri
    Hirschel, Bernard
    Vernazza, Pietro
    Weber, Rainer
    Joos, Beda
    Guenthard, Huldrych F.
    PLOS ONE, 2011, 6 (11):
  • [23] Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption
    Lu, Ching-Lan
    Pai, Joy A.
    Nogueira, Lilian
    Mendoza, Pilar
    Gruell, Henning
    Oliveira, Thiago Y.
    Barton, John
    Lorenzi, Julio C. C.
    Cohen, Yehuda Z.
    Cohn, Lillian B.
    Klein, Florian
    Caskey, Marina
    Nussenzweig, Michel C.
    Jankovic, Mila
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (48) : E11341 - E11348
  • [24] Venetoclax, alone and in combination with the BH3-mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Arandjelovic, P.
    Kim, Y.
    Cooney, J.
    Preston, S.
    Doerflinger, M.
    McMahon, J.
    Garner, S.
    Zerbato, J.
    Roche, M.
    Tumpach, C.
    Ong, J.
    Sheerin, D.
    Smyth, G.
    Anderson, J.
    Allison, C.
    Lewin, S.
    Pellegrini, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
  • [25] Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Arandjelovic, Philip
    Kim, Youry
    Cooney, James P.
    Preston, Simon P.
    Doerflinger, Marcel
    Mcmahon, James H.
    Garner, Sarah E.
    Zerbato, Jennifer M.
    Roche, Michael
    Tumpach, Carolin
    Ong, Jesslyn
    Sheerin, Dylan
    Smyth, Gordon K.
    Anderson, Jenny L.
    Allison, Cody C.
    Lewin, Sharon R.
    Pellegrini, Marc
    CELL REPORTS MEDICINE, 2023, 4 (09)
  • [26] Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA:: safety, immunogenicity and influence on viral load during treatment interruption
    Harrer, E
    Bäuerle, M
    Ferstl, B
    Chaplin, P
    Petzold, B
    Mateo, L
    Handley, A
    Tzatzaris, M
    Vollmar, J
    Bergmann, S
    Rittmaier, M
    Eismann, K
    Müller, S
    Kalden, JR
    Spriewald, B
    Willbold, D
    Harrer, T
    ANTIVIRAL THERAPY, 2005, 10 (02) : 285 - 300
  • [27] The latent reservoir for HIV-1 in resting CD4R T cells and other viral reservoirs during chronic infection: insights from treatment and treatment-interruption trials
    Haggerty, Christine M.
    Pitt, Eleanor
    Siliciano, Robert F.
    CURRENT OPINION IN HIV AND AIDS, 2006, 1 (01) : 62 - 68
  • [28] Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2-/-γc-/- Mouse
    Choudhary, Shailesh K.
    Rezk, Naser L.
    Ince, William L.
    Cheema, Manzoor
    Zhang, Liguo
    Su, Lishan
    Swanstrom, Ronald
    Kashuba, Angela D. M.
    Margolis, David M.
    JOURNAL OF VIROLOGY, 2009, 83 (16) : 8254 - 8258
  • [29] Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)
    Ben Farhat, Jihane
    Hessamfar, Mojgan
    Farbos, Sophie
    Desclaux, Arnaud
    Dumondin, Gilles
    Ferrand, Helene
    Greib, Carine
    Castan, Bernard
    Rispal, Patrick
    Duffau, Pierre
    Leleux, Olivier
    Perrier, Adelaide
    Wittkop, Linda
    Bonnet, Fabrice
    Barger, Diana
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 95 (01) : 1 - 5
  • [30] Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study) ( vol 95 , pg 1 , 2024)
    Ben Farhat, J.
    Hessamfar, M.
    Farbos, S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (01) : e3 - e3
123